Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Laurus Labs Ltd.
NSE: LAURUSLABS
|
BSE: 540222
|
ISIN: INE947Q01028
|
Industry: Pharmaceuticals
|
Strong Performer, Getting Expensive
864.2000
7.30
(
0.85
%)
NSE
Sep 01, 2025
10:50 AM
102.37% Gain from 52W Low
Volume:
329.1K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Laurus Labs Ltd.
25 Jan 2024
864.20
0.85%
Operating deleverage drags earnings
Buy:
Laurus Labs Ltd.
by
Motilal Oswal
Target: 440
Motilal Oswal
Number of FII/FPI investors increased from 259 to 293 in Jun 2025 qtr.
More from Laurus Labs Ltd.
Recommended
Market trades higher, Escorts Kubota's total wholesales grow 27.1% YoY to 8,456 units in August
Trendlyne Marketwatch |
01 Sep 2025, 11:10AM
Five Interesting Stocks Today - August 29, 2025
The Baseline |
29 Aug 2025
Earnings Call Transcript - Q1FY21 for Laurus Labs
|
31 Jul 2020, 12:02PM